PRADAXA 150 mg, granulés enrobés — 60 sachet(s) polytéréphtalate (PET) aluminium polyéthylène basse densité (PEBD) suremballée(s)/surpochée(s) aluminium

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930223970
  • CIP7 3022397
  • CIS 65548471
  • Registration number EU/1/08/442

What the source publishes

Holder
BOEHRINGER INGELHEIM INTERNATIONAL
Active ingredients
DABIGATRAN ÉTEXILATE, MÉSILATE DE DABIGATRAN ÉTEXILATE
Form
granulés enrobé
Package
60 sachet(s) polytéréphtalate (PET) aluminium polyéthylène basse densité (PEBD) suremballée(s)/surpochée(s) aluminium
Routes
orale
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration d'arrêt de commercialisation
Authorised on
2021-01-11
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930223970
{
  "cis": "65548471",
  "cip7": "3022397",
  "form": "granulés enrobé",
  "name": "PRADAXA 150 mg, granulés enrobés — 60 sachet(s) polytéréphtalate (PET) aluminium polyéthylène basse densité (PEBD) suremballée(s)/surpochée(s) aluminium",
  "cip13": "3400930223970",
  "holder": "BOEHRINGER INGELHEIM INTERNATIONAL",
  "routes": [
    "orale"
  ],
  "holders": [
    "BOEHRINGER INGELHEIM INTERNATIONAL"
  ],
  "currency": "EUR",
  "marketed": false,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": null,
  "authorisedOn": "2021-01-11",
  "compositions": [
    {
      "name": "DABIGATRAN ÉTEXILATE",
      "nature": "FT",
      "strength": "150 mg",
      "linkageNumber": "1",
      "substanceCode": "82447",
      "dosageReference": "un sachet",
      "pharmaceuticalElement": "granulés"
    },
    {
      "name": "MÉSILATE DE DABIGATRAN ÉTEXILATE",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "83321",
      "dosageReference": null,
      "pharmaceuticalElement": "granulés"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": null,
  "medicinePrice": null,
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "PRADAXA 150 mg, granulés enrobés",
  "marketingStatus": "Déclaration d'arrêt de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "60 sachet(s) polytéréphtalate (PET) aluminium polyéthylène basse densité (PEBD) suremballée(s)/surpochée(s) aluminium",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [],
  "marketingDeclaredOn": "2026-10-16",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "DABIGATRAN ÉTEXILATE",
    "MÉSILATE DE DABIGATRAN ÉTEXILATE"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/08/442",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930223970"